Proceedings of the 3rd International Conference on Obesity and Chronic Diseases (ICOCD-2018)

Keynote Presentations
Obesity-Associated Chronic Diseases Development: The Role of Gut Microbiota
Obesity has been an epidemic in the US and world for more than two decades. Obesity is associated with serious health conditions, including type 2 diabetes, cardiovascular disease, certain types of cancers, hyperlipidemia, and liver steatosis. The intestinal microbiota is composed of a diverse population of obligate and facultative anaerobic microorganisms, and these organisms carry out a broad range of metabolic activities. Obesity has been linked to changes in the intestinal microbiota, but the composition of the bacterial populations in lean and obese Zucker rats has not been carefully studied. The objective of this study was to determine the effects of obesity on the gut microbiota in this model. Lean and obese female Zucker rats (n = 16) were fed an AIN-93G diet for 8 weeks. Rats were weighed twice weekly, and fecal samples were collected at the beginning and end of the experiment. 16S rRNA gene sequencing was used to evaluate the composition of the fecal bacterial populations. At the outset of the study, the lean rats exhibited much lower ratios of the Firmicutes to Bacteroidetes phyla than the obese rats, but after 60 days, this ratio in the lean rats exceeded that of the obese. Obese rats also showed increased levels of the genus Akkermansia at day 60. PCoA plots of beta diversity showed clustering of the different test groups, indicating clear differences in intestinal microbiota populations associated with both the time point of the study and the lean or obese status. Since obesity is linked to the risk of development of different chronic diseases, this model would be valuable for investigation of the interrelationship of obesity and the intestinal microbiota on the development of several human obesity-related diseases. The benefit of using this obese model is that rats become obese in a short period of time which provides a better translation to obese humans.
Published on: September 06, 2018
doi: 10.17756/jocd.2018-suppl1
Citation: Proceedings of the 3rd International Conference on Obesity and Chronic Diseases (ICOCD-2018). J Obes Chronic Dis 2(Suppl 1): S1-S45.